Sunisam 50 mg Capsule: Advanced Sunitinib Therapy for Global Oncology Supply
Are you looking for a trusted Sunisam 50 mg Capsule exporter from India? Ernest Impex, a division of Group of Ernest Pharmaceutical Pvt. Ltd., is a leading global supplier, exporter, and bulk distributor of high-quality oncology medicines. We serve hospitals, oncology centers, wholesalers, and pharmaceutical distributors across Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica), ensuring timely and secure delivery of critical cancer treatments worldwide.
Detailed Product Overview: What is Sunisam 50 mg Capsule?
Sunisam 50 mg Capsule contains Sunitinib Malate 50 mg, a targeted anti-cancer medication belonging to the class of multi-targeted tyrosine kinase inhibitors (TKIs). It is widely prescribed for the treatment of advanced cancers by blocking multiple signaling pathways responsible for tumor growth, angiogenesis, and cancer cell survival.
Sunisam 50 mg is utilized globally in oncology treatment protocols and is considered an important therapeutic option for patients requiring targeted cancer therapy.
Therapeutic Indications
Sunisam 50 mg Capsule is commonly prescribed for:
Metastatic Renal Cell Carcinoma (mRCC)
Advanced kidney cancer that has spread beyond the kidney.
Gastrointestinal Stromal Tumors (GIST)
Treatment of GIST in patients who are resistant to or intolerant of Imatinib therapy.
Pancreatic Neuroendocrine Tumors (pNET)
For progressive, well-differentiated pancreatic neuroendocrine tumors.
Mechanism of Action
Sunisam 50 mg works by inhibiting multiple receptor tyrosine kinases involved in tumor growth and blood vessel formation.
VEGF Receptor Inhibition
Blocks VEGFR-1, VEGFR-2, and VEGFR-3, reducing tumor blood supply.
PDGF Receptor Blockade
Inhibits PDGFR-alpha and PDGFR-beta pathways responsible for tumor progression.
KIT and FLT3 Inhibition
Targets KIT and FLT3 receptors, helping suppress uncontrolled cancer cell proliferation.
Anti-Angiogenic Activity
Prevents formation of new blood vessels required for tumor growth and metastasis.
Administration and Storage
Recommended Dosage
Sunisam 50 mg Capsule should be taken exactly as prescribed by an oncologist. Treatment schedules may vary according to cancer type and patient response.
Storage Instructions
- Store below 30°C
- Keep in a cool and dry place
- Protect from direct sunlight and moisture
- Keep out of reach of children
Monitoring Requirements During Therapy
Cardiovascular Monitoring
Regular monitoring of blood pressure and cardiac function is recommended.
Thyroid Function Assessment
Periodic thyroid profile evaluation may be required.
Liver and Kidney Function Tests
Routine monitoring of liver and kidney parameters is advised.
Blood Sugar Monitoring
Patients should be observed for potential changes in glucose levels.
Why Choose Ernest Impex for Sunisam 50 mg Capsule?
Trusted Oncology Exporter from India
Reliable sourcing and international supply of quality oncology medicines.
Global Distribution Network
Efficient export services covering USA, UK, Australia, Thailand, Singapore, Jamaica, and additional international markets.
Regulatory Compliance
Support with export documentation, batch records, certificates of analysis (COA), and international shipping requirements.
Bulk Supply Solutions
Dedicated services for hospitals, distributors, pharmacies, government tenders, and healthcare procurement agencies.
Reliable Supply Chain Management
Consistent product availability and streamlined logistics for uninterrupted supply.
Contact Ernest Impex — Pharmaceutical Exporter from India
GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.
Websites:
www.ernestimpex.com
www.ernestvision.com
www.oncologymedicinesupplier.com
www.ernestpharmaceuticals.com
Email: exports@ernestpharmaceuticals.com
Business Type: Exporter | Bulk Supplier | Distributor
WhatsApp: +91 93599 02383
Direct WhatsApp: https://wa.me/919359902383
